China Medicine Corporation
CHME · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $9 | $11 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $17 | $25 | $22 | $22 |
| Inventory | $6 | $4 | $4 | $3 |
| Other Curr. Assets | $63 | $61 | $66 | $5 |
| Total Curr. Assets | $94 | $99 | $102 | $30 |
| Property Plant & Equip (Net) | $16 | $12 | $12 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $17 | $16 | $17 | $17 |
| Long-Term Investments | $0 | $0 | $8 | $8 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $8 | $0 | $0 |
| Total NC Assets | $40 | $36 | $36 | $37 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $134 | $135 | $139 | $67 |
| Liabilities | – | – | – | – |
| Payables | $1 | $3 | $3 | $1 |
| Short-Term Debt | $3 | $5 | $11 | $10 |
| Tax Payable | $2 | $3 | $2 | $2 |
| Deferred Revenue | $3 | $4 | $3 | $3 |
| Other Curr. Liab. | $3 | $1 | $2 | $1 |
| Total Curr. Liab. | $8 | $12 | $18 | $14 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $48 | $50 | $60 | $7 |
| Total NC Liab. | $48 | $50 | $60 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $56 | $62 | $78 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $25 | $23 | $18 | $23 |
| AOCI | $6 | $5 | $4 | $4 |
| Other Equity | $47 | $46 | $38 | $18 |
| Total Equity | $78 | $73 | $60 | $45 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $1 |
| Total Liab. & Tot. Equity | $134 | $135 | $139 | $67 |
| Net Debt | -$5 | -$4 | $0 | $9 |